ADUS
Price
$114.55
Change
+$2.63 (+2.35%)
Updated
Jul 24 closing price
Capitalization
2.14B
8 days until earnings call
Intraday BUY SELL Signals
CHE
Price
$511.13
Change
+$8.12 (+1.61%)
Updated
Jul 24 closing price
Capitalization
6.78B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADUS vs CHE

ADUS vs CHE Comparison Chart in %
View a ticker or compare two or three
VS
ADUS vs. CHE commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a StrongBuy and CHE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2026
Stock price -- (ADUS: $114.55 vs. CHE: $511.13)
Brand notoriety: ADUS and CHE are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ADUS: 45% vs. CHE: 58%
Market capitalization -- ADUS: $2.14B vs. CHE: $6.78B
ADUS [@Hospital/Nursing Management] is valued at $2.14B. CHE’s [@Hospital/Nursing Management] market capitalization is $6.78B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $84.78B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green whileCHE’s FA Score has 2 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • CHE’s FA Score: 2 green, 3 red.
According to our system of comparison, CHE is a better buy in the long-term than ADUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 4 TA indicator(s) are bullish while CHE’s TA Score has 5 bullish TA indicator(s).

  • ADUS’s TA Score: 4 bullish, 4 bearish.
  • CHE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ADUS and CHE are a bad buy in the short-term.

Price Growth

ADUS (@Hospital/Nursing Management) experienced а +0.03% price change this week, while CHE (@Hospital/Nursing Management) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.50%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was +25.57%.

Reported Earning Dates

ADUS is expected to report earnings on Aug 03, 2026.

CHE is expected to report earnings on Jul 28, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-2.50% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHE($6.79B) has a higher market cap than ADUS($2.14B). CHE has higher P/E ratio than ADUS: CHE (27.90) vs ADUS (21.15). CHE YTD gains are higher at: 19.776 vs. ADUS (6.667). CHE has higher annual earnings (EBITDA): 417M vs. ADUS (161M). ADUS has more cash in the bank: 103M vs. CHE (16.9M). ADUS has less debt than CHE: ADUS (139M) vs CHE (237M). CHE has higher revenues than ADUS: CHE (2.54B) vs ADUS (1.45B).
ADUSCHEADUS / CHE
Capitalization2.14B6.79B32%
EBITDA161M417M39%
Gain YTD6.66719.77634%
P/E Ratio21.1527.9076%
Revenue1.45B2.54B57%
Total Cash103M16.9M609%
Total Debt139M237M59%
FUNDAMENTALS RATINGS
ADUS vs CHE: Fundamental Ratings
ADUS
CHE
OUTLOOK RATING
1..100
5036
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
6892
SMR RATING
1..100
7437
PRICE GROWTH RATING
1..100
4241
P/E GROWTH RATING
1..100
6529
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHE's Valuation (12) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (66). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.

ADUS's Profit vs Risk Rating (68) in the Medical Or Nursing Services industry is in the same range as CHE (92). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.

CHE's SMR Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (74). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.

CHE's Price Growth Rating (41) in the Medical Or Nursing Services industry is in the same range as ADUS (42). This means that CHE’s stock grew similarly to ADUS’s over the last 12 months.

CHE's P/E Growth Rating (29) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (65). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADUSCHE
RSI
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
51%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
54%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 7 days ago
49%
Declines
ODDS (%)
Bearish Trend about 1 month ago
63%
Bearish Trend 4 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
62%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
ADUS
Daily Signal:
Gain/Loss:
CHE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BOME.X0.0004490.000020
+4.65%
BOOK OF MEME cryptocurrency
RARE.X0.0126290.000203
+1.64%
SuperRare cryptocurrency
ETH.X1873.22240013.045532
+0.70%
Ethereum cryptocurrency
PDA.X0.000845N/A
-0.01%
PlayDapp cryptocurrency
XEC.X0.000007N/A
-4.87%
eCash cryptocurrency

CHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+1.61%
UHS - CHE
36%
Loosely correlated
+2.96%
PNTG - CHE
32%
Poorly correlated
+3.39%
ENSG - CHE
32%
Poorly correlated
+3.27%
ADUS - CHE
31%
Poorly correlated
+2.35%
OPCH - CHE
25%
Poorly correlated
+2.75%
More